• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • ResearchMatch (RM)
    • Biomarkers
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page
New Jersey Innovation Institute’s BioCentriq Aims to Usher in a New Era in Cell and Gene Therapies

New Jersey Innovation Institute’s BioCentriq Aims to Usher in a New Era in Cell and Gene Therapies

by William Jester | Nov 18, 2020 | Community, News

To overcome production hurdles for cell and gene therapies, a promising new class of biologic medications, NJIT’s New Jersey Innovation Institute (NJII) has opened clinical-scale centers that will work directly with drug developers to streamline the processing of new...
Listen to Dr. Panettieri interview on the Pfizer vaccine

Listen to Dr. Panettieri interview on the Pfizer vaccine

by William Jester | Nov 18, 2020 | Community, Covid, News

Listen to Dr. Panettieri, the Vice Chancellor for Translational Medicine and Science at Rutgers University interview on 1010 WINS. As he reacts to Pfizer’s vaccine 95% effectiveness in preventing infections.
Coronavirus Test Results Are Faster but Still Too Slow for Contact Tracing, National Survey Says

Coronavirus Test Results Are Faster but Still Too Slow for Contact Tracing, National Survey Says

by William Jester | Nov 18, 2020 | Community, Covid, News

The average test times for coronavirus results have fallen from four days in April to 2.7 days in September, but results are still too slow for effective contact tracing, according to a new nationwide survey led by researchers from Rutgers University–New Brunswick and...
New Jersey Health Initiatives supports five NJ communities – resident’s perspective

New Jersey Health Initiatives supports five NJ communities – resident’s perspective

by Pamela Dahlen | Nov 17, 2020 | Community, News

Through a partnership with the New Jersey Healthy Communities Network (NJHCN) statewide funding collaborative, NJHI supports five New Jersey communities to ensure every resident has a fair and just opportunity to live the healthiest life possible. A Lindenwold...
RWJF allocates $5 million in pandemic aid to NJ

RWJF allocates $5 million in pandemic aid to NJ

by Pamela Dahlen | Nov 17, 2020 | Community, Covid, News

When RWJF allocated $5 million in pandemic response aid to its home state of New Jersey as part of $50 million given nationally, NJHI had the opportunity to tap into its networks of grantees and partners to understand what was happening on the ground, reimagine...
« Older Entries
Next Entries »

Recent Posts

  • Researchers Investigate How to Integrate Behavioral Health into Primary Care.
  • Scientists map the half-billion connections that allow mice to see.
  • New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains.
  • How a new library is set to transform this underserved N.J. community
  • Poll Finds Majority of New Jerseyans Give Negative Ratings to State and National Economy.

Archives

  • 2025
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,245)
  • Covid (985)
  • CTO Events (6)
  • News (2,860)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.